ARENA PHARMACEUTICALS INC
10-Q, EX-27.1, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: ARENA PHARMACEUTICALS INC, 10-Q, 2000-11-14
Next: ENTRUST PARTNERS L L C, 13F-HR, 2000-11-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                     144,648,198
<SECURITIES>                                         0
<RECEIVABLES>                                  950,000
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                           146,183,235
<PP&E>                                       4,877,915
<DEPRECIATION>                             (1,151,236)
<TOTAL-ASSETS>                             150,964,883
<CURRENT-LIABILITIES>                        2,153,796
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         2,268
<OTHER-SE>                                 146,355,089
<TOTAL-LIABILITY-AND-EQUITY>               150,964,883
<SALES>                                              0
<TOTAL-REVENUES>                             3,603,397
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                            13,218,632
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             177,083
<INCOME-PRETAX>                            (7,426,876)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (7,426,876)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (7,426,876)
<EPS-BASIC>                                     (4.91)
<EPS-DILUTED>                                   (4.91)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission